Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.870
-0.080 (-4.10%)
Apr 10, 2026, 4:00 PM EDT - Market closed
Stereotaxis Employees
Stereotaxis had 131 employees as of December 31, 2025. The number of employees decreased by 8 or -5.76% compared to the previous year.
Employees
131
Change (1Y)
-8
Growth (1Y)
-5.76%
Revenue / Employee
$247,153
Profits / Employee
-$174,916
Market Cap
182.28M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | -8 | -5.76% |
| Dec 31, 2024 | 139 | 17 | 13.93% |
| Dec 31, 2023 | 122 | -8 | -6.15% |
| Dec 31, 2022 | 130 | 0 | - |
| Dec 31, 2021 | 130 | 10 | 8.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Embecta | 1,850 |
| AngioDynamics | 675 |
| OraSure Technologies | 500 |
| Nyxoah | 184 |
| Pro-Dex | 181 |
| Anteris Technologies Global | 174 |
| Utah Medical Products | 152 |
| Sanara MedTech | 108 |
STXS News
- 6 days ago - Stereotaxis Announces FDA Clearance and Launch of Synchrony System - GlobeNewsWire
- 4 weeks ago - Stereotaxis Reports 2025 Full Year Financial Results - GlobeNewsWire
- 2 months ago - Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewsWire
- 2 months ago - Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program - GlobeNewsWire
- 3 months ago - Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter - GlobeNewsWire
- 4 months ago - Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - Stereotaxis Reports 2025 Third Quarter Financial Results - GlobeNewsWire
- 5 months ago - GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance - GlobeNewsWire